Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in
Principal investigator: Ulla Wartiovaara-Kautto
HUS, Helsinki University Hospital, Comprehensive Cancer Center
